• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LUTS 可能是 COVID-19 的早期症状。

Could LUTS be early symptoms of COVID-19.

机构信息

Department of Gynecology and Obstetrics Nursing, Faculty of Health Sciences, Eskişehir Osmangazi University, Eskişehir, Turkey.

Department of Urology, Eskisehir City Hospital, Eskişehir, Turkey.

出版信息

Int J Clin Pract. 2021 Mar;75(3):e13850. doi: 10.1111/ijcp.13850. Epub 2020 Dec 4.

DOI:10.1111/ijcp.13850
PMID:33222353
Abstract

AIM

To show if lower urinary tract symptoms (LUTS) could be symptoms of COVID-19 with validated questionnaires.

METHODS

The 96 COVID-19 patients who were hospitalised at a tertiary centre were collected retrospectively. After the exclusion criteria, 46 patients consisted the study population. All patients then fill formed the International Prostate Symptom Score and Urinary Symptom Profile respectively. All patients responded to these questions for the three period.

RESULTS

Twenty-seven female (58.6%) and 19 male (41.4%) COVID-19 patients answered the questions. In the male patients, while there were no statistically significant differences in the total IPSS, the voiding IPSS score, and quality of life between the three periods (P = .148; P = .933, P = .079, respectively), the storage IPSS scores had a significant difference between the three periods (P = .05). In female patients, low stream scores were similar between the three periods (P = .368). The scores of stress incontinence and an overactive bladder had a significant difference between the three periods (P = .05 and P = .05).

CONCLUSION

LUTS, especially storage symptoms, might be one of the initial symptoms of COVID-19 and the clinicians should evaluate LUTS with other known symptoms of the virus when a patient is suspected of having COVID-19.

摘要

目的

使用经过验证的问卷,表明下尿路症状(LUTS)是否可能是 COVID-19 的症状。

方法

回顾性收集了在一家三级中心住院的 96 名 COVID-19 患者。排除标准后,46 名患者纳入研究人群。所有患者随后分别填写了国际前列腺症状评分和尿症状谱。所有患者均在三个时期回答了这些问题。

结果

27 名女性(58.6%)和 19 名男性(41.4%)COVID-19 患者回答了这些问题。在男性患者中,虽然三个时期的总 IPSS、排尿 IPSS 评分和生活质量评分均无统计学差异(P=.148;P=.933,P=.079,分别),但存储 IPSS 评分在三个时期之间存在显著差异(P=.05)。在女性患者中,三个时期的低流评分相似(P=.368)。压力性尿失禁和膀胱过度活动症的评分在三个时期之间存在显著差异(P=.05 和 P=.05)。

结论

LUTS,尤其是存储症状,可能是 COVID-19 的初始症状之一,当患者疑似感染 COVID-19 时,临床医生应结合该病毒的其他已知症状评估 LUTS。

相似文献

1
Could LUTS be early symptoms of COVID-19.LUTS 可能是 COVID-19 的早期症状。
Int J Clin Pract. 2021 Mar;75(3):e13850. doi: 10.1111/ijcp.13850. Epub 2020 Dec 4.
2
Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.国际前列腺症状评分和核心下尿路症状评分评估男性下尿路症状。
BJU Int. 2012 May;109(10):1512-6. doi: 10.1111/j.1464-410X.2011.10445.x. Epub 2011 Aug 26.
3
Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.在患有下尿路症状和膀胱过度活动症的男性中,使用或不使用坦索罗辛的缓释托特罗定:对通过国际前列腺症状评分评估的泌尿症状的影响。
BJU Int. 2008 Nov;102(9):1133-9. doi: 10.1111/j.1464-410X.2008.07761.x. Epub 2008 May 26.
4
Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study.中国大陆、中国台湾地区和韩国下尿路症状及膀胱过度活动症严重程度与生活质量和心理健康的关联:一项基于人群的横断面研究结果
BMC Urol. 2017 Nov 21;17(1):108. doi: 10.1186/s12894-017-0294-3.
5
Moving towards a comprehensive assessment of lower urinary tract symptoms (LUTS).迈向全面评估下尿路症状(LUTS)。
Neurourol Urodyn. 2012 Apr;31(4):448-54. doi: 10.1002/nau.21202. Epub 2012 Mar 6.
6
Lower Urinary Tract Symptoms and Urinary Bother Are Common in Patients Undergoing Elective Cervical Spine Surgery.在接受择期颈椎手术的患者中,下尿路症状和排尿困扰较为常见。
Clin Orthop Relat Res. 2019 Apr;477(4):872-878. doi: 10.1097/CORR.0000000000000666.
7
Core lower urinary tract symptom score (CLSS) for the assessment of female lower urinary tract symptoms: a comparative study.核心下尿路症状评分(CLSS)用于评估女性下尿路症状:一项比较研究。
Int J Urol. 2011 Nov;18(11):778-84. doi: 10.1111/j.1442-2042.2011.02848.x. Epub 2011 Sep 23.
8
Investigation on lower urinary tract symptoms (LUTS) in elderly patients with prostate cancer (PC) received endocrine therapy.
Arch Gerontol Geriatr. 2015 May-Jun;60(3):535-7. doi: 10.1016/j.archger.2014.10.014. Epub 2014 Nov 6.
9
Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN).索利那新联合坦索罗辛 OCAS 治疗排尿和储尿期下尿路症状男性患者的疗效和安全性:一项 2 期剂量探索研究(SATURN)的结果。
Eur Urol. 2013 Sep;64(3):398-407. doi: 10.1016/j.eururo.2013.03.031. Epub 2013 Mar 19.
10
Debilitating lower urinary tract symptoms in the post-renal transplant population can be predicted pretransplantation.移植后人群中令人虚弱的下尿路症状在移植前即可预测。
Transplantation. 2013 Feb 27;95(4):589-94. doi: 10.1097/TP.0b013e3182782f7e.

引用本文的文献

1
Prolonged urinary retention in COVID-19 survivors: observational study.COVID-19 幸存者的长期尿潴留:观察性研究。
Rev Assoc Med Bras (1992). 2024 Nov 11;70(11):e20240845. doi: 10.1590/1806-9282.20240845. eCollection 2024.
2
The Impact of SARS-CoV-2 on Patients With Lower Urinary Tract Symptoms (LUTS).严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对下尿路症状(LUTS)患者的影响。
Cureus. 2024 Apr 27;16(4):e59148. doi: 10.7759/cureus.59148. eCollection 2024 Apr.
3
COVID-associated cystitis: the culprit behind the bladder woes post-COVID infection? A review.
COVID 相关性膀胱炎:COVID 感染后膀胱不适的罪魁祸首?综述。
Int Urol Nephrol. 2023 Oct;55(10):2367-2372. doi: 10.1007/s11255-023-03700-3. Epub 2023 Jul 6.
4
De Novo Lower Urinary Tract Symptoms in COVID-19 Patients.新冠病毒感染患者的新发下尿路症状
Cureus. 2023 Jan 18;15(1):e33947. doi: 10.7759/cureus.33947. eCollection 2023 Jan.
5
The Influence of SARS-CoV-2 on Minimally Invasive Therapeutic Approach for Benign Prostatic Hyperplasia.严重急性呼吸综合征冠状病毒2对良性前列腺增生微创治疗方法的影响
Maedica (Bucur). 2022 Dec;17(4):785-788. doi: 10.26574/maedica.2022.17.4.785.
6
Urological complications of COVID-19: a systematic review.新型冠状病毒肺炎的泌尿系统并发症:系统评价。
Int Braz J Urol. 2023 Jan-Feb;49(1):24-40. doi: 10.1590/S1677-5538.IBJU.2022.0281.
7
Evaluation of lower urinary tract symptoms among male COVID-19 patients during the second wave: An observational study.第二波疫情期间男性新冠病毒肺炎患者下尿路症状的评估:一项观察性研究
Urol Ann. 2022 Oct-Dec;14(4):372-376. doi: 10.4103/ua.ua_140_21. Epub 2022 Sep 7.
8
Evaluation of Overactive Bladder Symptoms in Patients Recovering from Post-Acute COVID-19 Syndrome.急性后新冠综合征康复患者膀胱过度活动症症状评估
J Multidiscip Healthc. 2022 Oct 26;15:2447-2452. doi: 10.2147/JMDH.S384436. eCollection 2022.
9
Molecular detection of the COVID-19 genome in prostatic tissue of patients with previous infection.既往感染过新冠病毒的患者前列腺组织中新冠病毒基因组的分子检测
Proc (Bayl Univ Med Cent). 2022 Jul 19;35(6):759-761. doi: 10.1080/08998280.2022.2101178. eCollection 2022.
10
SARS-CoV-2 Effects on the Male Genitourinary System.严重急性呼吸综合征冠状病毒2对男性生殖泌尿系统的影响。
Am J Clin Exp Urol. 2022 Aug 15;10(4):199-209. eCollection 2022.